Endogenous cathelicidin protects against Toxoplasma gondii- associated liver damage
Open Access
- 12 May 2026
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 94 (5) , e0070825
Abstract
Toxoplasmosis, a disease caused by apicomplexan Toxoplasma gondii (Tg) , is associated with various neuropsychiatric and behavioral conditions. Toxoplasmosis can cause serious complications for those with weakened immune systems and during pregnancy. Cathelicidins, peptides with antimicrobial and immunomodulatory functions, are critical factors in host defense against microbes, but their role in parasitic infections is less well understood. This study demonstrates the protective function of endogenous cathelicidin against hepatic damage caused by Tg infection in an oral infection model. We challenged wild-type ( Camp +/+ ) and cathelicidin-deficient ( Camp -/- ) mice with low-virulent Type II strain of Tg (ME-49) cysts. Our findings demonstrate that Camp -/- mice exhibited more severe clinical manifestations, higher mortality rates, and more pronounced hepatic damage compared to their Camp +/+ counterparts. Histological liver examinations indicated significant necrotic hepatitis in Camp -/- mice, correlating with increased local concentrations of pro-inflammatory cytokines and proteomic upregulation of poly(ADP-ribose) polymerase 3 and guanylate-binding proteins. Increased cerebral inflammation and Tg cystogenesis were also observed in Camp -/- mice. Systemically, Camp -/- mice presented elevated levels of pro-inflammatory mediators, specifically interferon-gamma (Ifn-γ) and tumor necrosis factor-alpha (Tnf-α). In cultured macrophages, endogenous cathelicidin increased after Tg challenge, while Camp -/- bone marrow-derived macrophages released higher amounts of Tnf-α than their counterparts. We conclude that cathelicidin protects against liver injury and systemic deterioration induced by Tg infection by downregulating the synthesis of pro-inflammatory cytokines.Keywords
Funding Information
- Alberta Provincial Government Agriculture Funding Consortium/Results Driven Agriculture Research (2023F205R)
- Alberta Provincial Government Agriculture Funding Consortium/Results Driven Agriculture Research (2024F2443R)
- Government of Canada New Frontiers in Research Fund (NFRFE/00280-2024)
- Alberta Government Major Innovation Fund (RCP-19-003-MIF)
- Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery (RGPAS-2024)
This publication has 76 references indexed in Scilit:
- Human cathelicidin LL-37 rapidly disrupted colonic epithelial integrityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2025
- microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains)Acta Parasitologica, 2021
- Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3Neurotherapeutics, 2021
- Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in macrophagesCell and tissue research, 2019
- The Role of Cathelicidin LL-37 in Cancer DevelopmentArchivum Immunologiae et Therapiae Experimentalis, 2015
- Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: Possible implications for rosaceaJournal of Dermatological Science, 2014
- Poly (ADP-Ribose) Polymerase-1 Is a Key Mediator of Liver Inflammation and FibrosisHepatology, 2013
- Toxoplasmosis: A history of clinical observationsInternational Journal for Parasitology, 2009
- CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infectionsInternational Journal of Medical Microbiology, 2008
- Cathelicidin stimulates colonic mucus synthesis by up‐regulatingMUC1andMUC2expression through a mitogen‐activated protein kinase pathwayJournal of Cellular Biochemistry, 2007